<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01385514</url>
  </required_header>
  <id_info>
    <org_study_id>1042-2011</org_study_id>
    <nct_id>NCT01385514</nct_id>
  </id_info>
  <brief_title>Staphylococcus Aureus Skin and Soft Tissue Infections</brief_title>
  <official_title>Evaluating Strategies to Prevent Staphylococcus Aureus Skin and Soft Tissue Infections in Soldiers During Infantry Training</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Corps, Israel Defense Force</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Corps, Israel Defense Force</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate strategies to prevent Staphylococcus aureus skin and
      soft tissue infections in soldiers during infantry training.

      This study will be conducted on three different bases among groups of male recruits to IDF
      training base. They will provide nasal swabs to detect Staphylococcus aureus carriage in two
      time points: 1. before mixing and training in confined settings, reflecting carriage acquired
      before entering 2. After 14-30 days. All soldiers will be under surveillance for skin
      infection until the end of the training program.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1050</enrollment>
  <condition>Staphylococcus Aureus</condition>
  <arm_group>
    <arm_group_label>company A-Training Base No.1</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>company A-Training Base No.2</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>company A-Training Base No.3</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      nasal swabs to detect Staphylococcus aureus skin infection to detect Staphylococcus aureus
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        the population of the study will be selected from infantry training bases in the IDF
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  new recruit for a combat training unit
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Hartal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>International Diabetes Federation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Hartal, MD</last_name>
    <phone>+972-3-7374137</phone>
    <email>Mhuerta2@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Israeli Defense Forces</name>
      <address>
        <city>Tel aviv</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2011</study_first_submitted>
  <study_first_submitted_qc>June 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2011</study_first_posted>
  <last_update_submitted>March 22, 2012</last_update_submitted>
  <last_update_submitted_qc>March 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 23, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Soft Tissue Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

